Steven Katz, MD, on Assessing New Delivery Methods for CAR T-Cell TherapyBySteven Katz, MDJuly 1st 2023The chief medical officer of Trisalus Life Sciences discussed studies evaluating the company’s PEDD system.
Steven Katz, MD, on Tackling TME Immunosuppression, Intratumoral Pressure BySteven Katz, MDMay 2nd 2023The chief medical officer of Trisalus Life Sciences discussed the company’s PEDD system and SD-101.